Graph Therapeutics: Funding, Investors & Team (Sep 2026)
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left without adequate treatment options - and AI trained with complex disease data can solve this.
Graph Therapeutics has raised $8.1M across 2 funding rounds on record, the most recent a Seed of $5.0M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Graph Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Graph Therapeutics Funding Rounds
Graph Therapeutics raised $3.1M in a Pre-Seed announced in Jan 2025.
1.4 years later, a Seed of $5.0M was announced in Jun 2026.
Graph Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Graph Therapeutics Funding Compared to Other Biotechnology Startups
Graph Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Graph Therapeutics in Biotechnology and Klosterneuburg
Companies Similar to Graph Therapeutics
VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments,…
aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision…
Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest…
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious…
The patented technology developed by Lignovations allows for the creation of lignin particles in the…
Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal…
Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into…
Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Graph Therapeutics Funding FAQs
What does Graph Therapeutics do?
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left without adequate treatment options - and AI trained with complex disease data can solve this.
How much funding has Graph Therapeutics raised?
Graph Therapeutics has raised $8.1M across 2 rounds on record. The most recent is a Seed of $5.0M announced in Jun 2026.
When did Graph Therapeutics last raise funding?
Graph Therapeutics' most recent funding round on record is a Seed of $5.0M, announced in Jun 2026.
Who founded Graph Therapeutics?
FundedIQ lists Greg Vladimer (Founder), Gregory Vladimer (Founder) at Graph Therapeutics.
Where is Graph Therapeutics headquartered?
Graph Therapeutics is based in Klosterneuburg, Niederosterreich, Austria.
How many employees does Graph Therapeutics have?
Graph Therapeutics is in the 1-10 employee band.
How does Graph Therapeutics' funding compare to other Biotechnology startups?
Graph Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Graph Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Graph Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.